Savolitinib versus sunitinib in patients with MET-driven, unresectable and locally advanced or...
Read More
Safety of Nivolumab in Patients With Clear Cell (CC) or Non-Clear Cell (NCC) Renal Cell Carcinoma...
Read More
Rheumatologic adverse events in patients with metastatic renal cell carcinoma treated with immune...
Read More
Results of lymph node dissection for locally advanced and metastatic renal cell carcinoma Abstract...
Read More
Quality-adjusted survival of nivolumab vs. everolimus in patients with previously treated advanced...
Read More